67401-65-4 Usage
General Description
"(R)-2-(methoxycarbonylamino)-3-phenylpropanoic acid" is a chemical compound with the molecular formula C12H15NO5. It is a carboxylic acid derivative, containing a phenyl group and an amino group. (R)-2-(methoxycarbonylamino)-3-phenylpropanoic acid may have potential applications in pharmaceuticals and drug synthesis due to its structural features and functional groups. It could potentially be used as a building block for the synthesis of various biologically active compounds. Further research and characterization of this chemical are necessary to fully understand its potential uses and properties.
Check Digit Verification of cas no
The CAS Registry Mumber 67401-65-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,7,4,0 and 1 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 67401-65:
(7*6)+(6*7)+(5*4)+(4*0)+(3*1)+(2*6)+(1*5)=124
124 % 10 = 4
So 67401-65-4 is a valid CAS Registry Number.
67401-65-4Relevant articles and documents
HPTP-BETA INHIBITORS
-
Paragraph 0213-0214, (2015/10/05)
Disclosed herein are compounds effective for activation of Tie-2 and inhibition of HPTP-beta. The compounds can provide effective therapy for conditions associated with angiogenesis, for example, ocular conditions. Formulations for increased solubility ar
HEPATITIS C VIRUS INHIBITORS
-
Page/Page column 237; 239, (2012/04/10)
This disclosure concerns novel compounds of Formula (I) as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds
HEPATITIS C VIRUS INHIBITORS
-
Page/Page column 88, 90, (2011/06/16)
The present disclosure relates to methods for making compounds useful in the treatment of Hepatitis C virus (HCV) infection.
